<div>National Pharmaceutical Pricing Authority (NPPA) has decided not to stop any coronary stent manufacturer from withdrawing products from the Indian market.&nbsp;</div>''<div><br />''</div>''<div>However, the authority said, companies will have to follow mandatory requirement of informing it six months prior to the intended date of discontinuation besides other formalities.&nbsp;</div>''<div><br />''</div>''<div>Last week, the government had revised ceiling prices of bare metal stents and drug eluting stents, almost a year after it slashed rates of coronary stents by up to 85 per cent.&nbsp;</div>''<div><br />''</div>''<div>In case of bare metal stents, the government has increased the prices from current 7,400 to 7,660 rupees.&nbsp;</div>''<div><br />''</div>